NCT05010356View on ClinicalTrials.gov

Insulin Sensitivity After Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

September 30, 2026

Conditions
Insulin Sensitivity/ResistanceBreast CancerSurvivorshipMetabolic Disturbance
Interventions
DRUG

Insulin

Hyperinsulinemic euglycemic clamp

Trial Locations (1)

2100

RECRUITING

University of Copenhagen, Copenhagen

All Listed Sponsors
lead

University of Copenhagen

OTHER